Scholar

John De Vos

Videos
H-index: 70
Biology 37%
Environmental science 10%
more

Reposted by: John De Vos

alexis-verger.cpesr.fr
Will chemists be happy tomorrow 🍾, or will they say, “Here we go again with biology” 😡 for the Nobel Prize in Chemistry? #chemnobel 😬
3 1 28

Reposted by: John De Vos

Reposted by: John De Vos

elife.bsky.social
1/ We’re delighted to hear that our Reviewing Editor, Shimon Sakaguchi, has been awarded the 2025 Nobel Prize in Physiology and Medicine today alongside colleagues Fred Ramsdell and Mary Brunkell: www.nobelprize.org
The official website of the Nobel Prize - NobelPrize.org
The Nobel Prize rewards science, humanism and peace efforts. This is one of the central concepts in the will of Alfred Nobel, and it also permeates the outreach activities that have been developed for...
www.nobelprize.org
1 6 27

by John De Vos

jdevos.bsky.social
Immunology is back in the spotlight! The 2025 Nobel Prize in Physiology or Medicine has been awarded to research on TReg lymphocytes.

www.nobelprize.org/prizes/medic...

#NobelPrize
1 3

by John De Vos

Reposted by: John De Vos

itaiyanai.bsky.social
Congratulations to Mary Brunkow, Fred Ramsdell and Shimon Sakaguchi for this year's Nobel Prize in Physiology or Medicine. It also demonstrates the fairness of the prize, as Mary Brunkow is a Senior Program Manager (not a professor) at the @isbscience.org
hood.isbscience.org/people/mary-...
2 14 39

Reposted by: John De Vos

albertvilella.bsky.social
@rohanpaul.bsky.social , not active on #Bluesky, on the comparisons between the AI revolution and the dot-com bubble of the 2000s.
1 2 7

by Naftali Kaminski — Reposted by: John De Vos

Reposted by: John De Vos

Reposted by: John De Vos

Reposted by: John De Vos

Reposted by: John De Vos

Reposted by: John De Vos, Jonathan M. Metzl

by John De Vos

by John De Vos

jdevos.bsky.social
Regenerative cell therapy marches into corneal blindness

Human endothelial cells (CHECs) can reduce corneal edema and opacity, are approved in Japan in 2023 for bullous keratopathy and in phase III in the US.

www.nature.com/articles/s41...
Regenerative cell therapy marches into corneal blindness - Nature Biotechnology
With a newly marketed product in Japan and 10 years of clinical data, regenerative cell therapies promise new options for patients facing a choice between invasive surgery or blindness.
www.nature.com
1 4

Reposted by: John De Vos, Kim L. Scheppele, Naftali Kaminski , and 2 more

by John De Vos

by John De Vos

jdevos.bsky.social
Derivation of embryonic stem cells across 8 avian species including chicken.

buff.ly/ZA7QdIy
#ESCells #PSCells #Pluripotency
2

by John De Vos

by John De Vos

jdevos.bsky.social
In vivo chimeric antigen receptor (CAR)-T cell therapy : a review by C. June et al. in Nature Reviews Drug Discovery.

👉🏻 buff.ly/XhyYwfe
#CARTCells
2

by John De Vos

Reposted by: John De Vos

labwaggoner.bsky.social
Review @natrevdrugdiscov.nature.com
In vivo chimeric antigen receptor (#CAR)-T cell therapy
www.nature.com/articles/s41...
2 8

Reposted by: John De Vos, Steve Keen

Reposted by: John De Vos

natbiotech.nature.com
Design of optimized epigenetic regulators for durable gene silencing with application to PCSK9 in nonhuman primates go.nature.com/46uDMyK
Design of optimized epigenetic regulators for durable gene silencing with application to PCSK9 in nonhuman primates - Nature Biotechnology
Sustained epigenetic silencing in monkeys is made more efficient with optimized regulators.
go.nature.com
1 2

Reposted by: John De Vos

by John De Vos

jdevos.bsky.social
👏🏻 Successful gene therapy for hereditary ATTR with polyneuropathy was achieved in a phase I study of 36 patients using a single intravenous infusion.

nej.md/46Qhur7
1 2

by John De Vos

by John De Vos

jdevos.bsky.social
Merci!
Île de Maïre, et j’aime la vision qu’en a Vincent Bioulès.

Reposted by: John De Vos

by John De Vos

jdevos.bsky.social
A first participant received randomized treatment in the pivotal Phase III clinical trial, exPDite-2, of bemdaneprocel, dopamine producing neuron precursors derived from human embryonic pluripotent stem cells.

buff.ly/Rjr3fFV
1

References

Fields & subjects

Updated 1m